Drug Trial Radar · NCT05550207
Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
Last checked: Nov 19, 2026Latest source record: Dec 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Aug 31, 2022
Primary completion
Nov 27, 2024
Study completion Nov 27, 2024
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 22, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label trial to evaluate the efficacy and safety of AXS-07 in subjects with migraine attacks and prior inadequate response to oral CGRP inhibitors.
Conditions
- Migraine
Interventions
AXS-07 (meloxicam-rizatriptan)Drug
AXS-07 tablets, taken orally for the acute treatment of migraine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of subjects with headache pain reliefTime frame: Hour 2 following dose administration
- Percentage of subjects with absence of the Most Bothersome SymptomTime frame: Hour 2 following dose administration
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Colton, California
Clinical Research Site
Fullerton, California
Clinical Research Site
La Jolla, California
Clinical Research Site
Los Angeles, California
Clinical Research Site
Sherman Oaks, California
Clinical Research Site
Stamford, Connecticut
Clinical Research Site
DeLand, Florida
Clinical Research Site
Hallandale, Florida
Clinical Research Site
Hollywood, Florida
Clinical Research Site
Miami, Florida
Clinical Research Site
Ormond Beach, Florida
Clinical Research Site
Oviedo, Florida
Clinical Research Site
Pensacola, Florida
Clinical Research Site
Winter Park, Florida
Clinical Research Site
Stockbridge, Georgia
Clinical Research Site
Avon, Indiana
Clinical Research Site
Boston, Massachusetts
Clinical Research Site
North Dartmouth, Massachusetts
Clinical Research Site
Las Vegas, Nevada
Clinical Research Site
Albuquerque, New Mexico
Clinical Research Site
The Bronx, New York
Clinical Research Site
Williamsville, New York
Clinical Research Site
Philadelphia, Pennsylvania
Clinical Research Site
Charleston, South Carolina
Clinical Research Site
Knoxville, Tennessee
Clinical Research Site
Nashville, Tennessee
Clinical Research Site
Cypress, Texas
Clinical Research Site
Sugar Land, Texas
Clinical Research Site
Salt Lake City, Utah
Clinical Research Site
Charlottesville, Virginia
Clinical Research Site
McLean, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.